January 5, 2018 / 2:15 PM / in 7 minutes BRIEF-Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook Reuters Staff 
Jan 5 (Reuters) - Diplomat Pharmacy Inc: 
* - EXPECTS 2017 REVENUE TO BE NEAR MIDDLE OF PREVIOUSLY PROVIDED RANGE 
* FY2018 EARNINGS PER SHARE VIEW $0.95, REVENUE VIEW $5.38 BILLION -- THOMSON REUTERS I/B/E/S 
* DIPLOMAT REAFFIRMS 2017 GUIDANCE, PROVIDES PRELIMINARY 2018 OUTLOOK * SEES FY 2018 REVENUE UP ABOUT 20 PERCENT * SEES FY 2018 REVENUE $5.3 BILLION TO $5.6 BILLION 
* - IN 2018, EXPECTS ADJUSTED EBITDA IN RANGE OF $164 TO $170 MILLION Source text for Eikon: Further company coverage: